News
Merck (MRK) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q4 2023 Earnings CallFeb 01, 2024, 9:00 a.m. ET
Operator
Source Fool.com
Plug Power Stock Keeps Rolling. Is It Time to Buy?
Plug Power (NASDAQ: PLUG) stock just keeps plugging ahead. It jumped as much as 15.5% today. Even though it pared those gains to 4.7% as of 12:15 p.m. ET, shares of the hydrogen fuel company are
Why Is Plug Power Stock Going Parabolic Today?
Plug Power (NASDAQ: PLUG) is on fire this morning, surging 15% as of 9:40 a.m. ET Thursday. The hydrogen stock has gained massive momentum recently and is now up a staggering 50% in just five days
3 Growth Stocks That Have Raised Their Dividends for the Past 14+ Years
Some of the best dividend stocks don't have the best yields -- yet. And that's because their businesses are still experiencing some strong growth and they have to set some cash aside to help fund
Is Amgen Stock a Buy Now?
The biotech industry has been in a slump over the past two years, but Amgen (NASDAQ: AMGN) has performed comparatively well. That's not to say this leading drugmaker hasn't had its share of issues
AT&T's 6.4% Yield Looks Great After Earnings... But There's Bad News, Too
U.S. wireless carrier AT&T (NYSE: T) recently closed out its fiscal 2023 year with earnings. The company, popular with income-focused investors, got great news regarding its financials and how they
Is AT&T's Dividend in Danger After the Company Posted an Underwhelming Q4?
AT&T (NYSE: T) currently pays a dividend that yields 6.4%. That's more than four times the S&P 500 average of around 1.5%. While it does offer a mouthwatering payout for income investors, there's
Could Novavax Stock Help You Become a Millionaire?
Novavax (NASDAQ: NVAX) stock may have made some millionaires back in 2020. It was the height of the coronavirus vaccine race, and investors were betting on this biotech company making it to the
Is the Worst Over for Pfizer?
Pfizer (NYSE: PFE) celebrates its 175th anniversary this year, so the pharma giant has a long history. But the drugmaker actually jumped into the global spotlight not long ago when it launched its
Novartis Ag (NVS) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Novartis Ag (NYSE: NVS)Q4 2023 Earnings CallJan 31, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Why Plug Power Stock Jumped Again Today
Shares of hydrogen fuel cell company Plug Power (NASDAQ: PLUG) continued to soar again today. Over the past five trading days, the stock has jumped by more than 25%. There have been several
2 Stocks That Look Dirt Cheap in 2024
We're one month into 2024, and the stock market is in full-on bull mode. The S&P 500 index has climbed roughly 2.5% year to date and gone on to set new record highs.
But even though the benchmark
Why Vertex Pharmaceuticals Stock Topped the Market Today
Good news from the lab sparked a mini-rally in Vertex Pharmaceuticals (NASDAQ: VRTX) stock on Tuesday. The biotech's shares closed the trading session more than 2% higher in price, which was good
Pfizer (PFE) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Pfizer (NYSE: PFE)Q4 2023 Earnings CallJan 30, 2024, 10:00 a.m. ET
Operator
Source Fool.com
Why Pfizer Stock Was Jumping Today, but Then Gave Up Its Gains
Shares of Pfizer (NYSE: PFE) jumped as much as 3.2% higher on Tuesday morning before giving up all of the gains and then some. The pharma stock was down by 0.6% as of 12:05 p.m. ET.
These gyrations
The S&P 500 Just Hit Another All-Time High: 3 Growth Stocks to Buy Hand Over Fist Now
Almost daily the S&P 500 index sets a new high, driven by increasing optimism about the growth prospects of the U.S. economy and cooling inflation in 2024.
Many growth stocks, especially technology
EQS-News: MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability
Valbiotis presents its 2024 financial communication calendar
Better Telecom Stock: AT&T vs. Verizon
AT&T (NYSE: T) and Verizon Communications (NYSE: VZ) have delivered their 2023 results to shareholders. Although investors had differing reactions to both of these stocks, both reported strong
Is Amgen a Good Dividend Stock to Buy Right Now?
As dividend investors know, there's an upside to investing in a big pharmaceutical business like Amgen (NASDAQ: AMGN) for dividend income. It likely has the resources and proven capabilities that'll
1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell
Like many of the biotechs pursuing coronavirus vaccine development, Novavax (NASDAQ: NVAX) has seen better days. Its shares are down by 96% over the past three years, and the company's remaining
A Bull Market Is Here: 2 Cheap Stocks to Buy Right Now
Famed investor Warren Buffett once said he aimed to be greedy when others were fearful. Here's one way to apply this bit of advice when investing in stocks: Equities that look beaten-down can be
Better Buy in 2024: The "Magnificent Seven" or the "Terrific 10"?
Microsoft, Apple, Nvidia, Amazon, Alphabet, Meta Platforms, and Tesla -- a group that Bank of America analyst Michael Hartnett dubbed the "Magnificent Seven," -- have taken the market by storm for
Is Invitae Stock a Buy Now?
Invitae (NYSE: NVTA) has grown revenue over time, but the genetic testing specialist has failed to turn that into profit. Instead, the company burned through more and more cash, prompting it to